Circulating tumor cell as a biomarker for evaluating allogenic NK cell immunotherapy on stage IV non-small cell lung cancer. [electronic resource]
Producer: 20180206Description: 10-15 p. digitalISSN:- 1879-0542
- Adult
- Aged
- Antigens, Neoplasm -- metabolism
- Biomarkers, Tumor -- metabolism
- Carcinoembryonic Antigen -- metabolism
- Carcinoma, Non-Small-Cell Lung -- diagnosis
- Female
- Humans
- Immunotherapy, Adoptive -- methods
- Keratin-18 -- metabolism
- Killer Cells, Natural -- immunology
- Lung Neoplasms -- diagnosis
- Lymphocyte Count
- Male
- Middle Aged
- Neoplasm Proteins -- metabolism
- Neoplasm Staging
- Neoplastic Cells, Circulating -- pathology
- Prognosis
- Transplantation, Homologous
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.